These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36234680)

  • 1. DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway.
    Al-Mutairi MS; Habashy HO
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.
    Du F; Yu L; Wu Y; Wang S; Yao J; Zheng X; Xie S; Zhang S; Lu X; Liu Y; Chen W
    Cell Death Dis; 2019 Dec; 10(12):922. PubMed ID: 31801953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
    Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
    Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
    Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
    Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW; Shi YY; Higgins LS; Orlowski RZ
    Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of mitogen-activated protein kinase phosphatase-2 enhances adhesion molecule expression and protects against apoptosis in human endothelial cells.
    Al-Mutairi M; Al-Harthi S; Cadalbert L; Plevin R
    Br J Pharmacol; 2010 Oct; 161(4):782-98. PubMed ID: 20860659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity.
    Haagenson KK; Zhang JW; Xu Z; Shekhar MP; Wu GS
    Oncotarget; 2014 Feb; 5(4):1101-10. PubMed ID: 24658355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
    Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MKP-7, a negative regulator of JNK, regulates VCAM-1 expression through IRF-1.
    Nizamutdinova IT; Kim YM; Lee JH; Chang KC; Kim HJ
    Cell Signal; 2012 Apr; 24(4):866-72. PubMed ID: 22182512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2.
    Cadalbert LC; Sloss CM; Cunningham MR; Al-Mutairi M; McIntire A; Shipley J; Plevin R
    Cell Signal; 2010 Mar; 22(3):357-65. PubMed ID: 19843478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
    Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
    Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
    Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
    Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2.
    Gopallawa I; Uhal BD
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L240-8. PubMed ID: 26637635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
    Mei Y; Liao X; Zhu L; Yang H
    J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
    Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M
    J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
    Yang T; Xiao Y; Liu S; Luo F; Tang D; Yu Y; Xie Y
    Phytomedicine; 2023 Jun; 114():154780. PubMed ID: 37004402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
    Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
    Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
    Lee MG; Lee KS; Nam KS
    IUBMB Life; 2023 Sep; 75(9):765-777. PubMed ID: 37492896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer.
    Turner-Ivey B; Manevich Y; Schulte J; Kistner-Griffin E; Jezierska-Drutel A; Liu Y; Neumann CA
    Oncogene; 2013 Nov; 32(45):5302-14. PubMed ID: 23334324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway.
    Zhang Z; Zhang H; Li D; Zhou X; Qin Q; Zhang Q
    J Cell Mol Med; 2021 Sep; 25(17):8159-8168. PubMed ID: 34369076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.